Correlation Between Edgewise Therapeutics and Organon
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Organon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Organon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Organon Co, you can compare the effects of market volatilities on Edgewise Therapeutics and Organon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Organon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Organon.
Diversification Opportunities for Edgewise Therapeutics and Organon
-0.85 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Edgewise and Organon is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Organon Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organon and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Organon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organon has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Organon go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Organon
Given the investment horizon of 90 days Edgewise Therapeutics is expected to generate 2.12 times more return on investment than Organon. However, Edgewise Therapeutics is 2.12 times more volatile than Organon Co. It trades about 0.08 of its potential returns per unit of risk. Organon Co is currently generating about -0.02 per unit of risk. If you would invest 850.00 in Edgewise Therapeutics on August 28, 2024 and sell it today you would earn a total of 2,348 from holding Edgewise Therapeutics or generate 276.24% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Edgewise Therapeutics vs. Organon Co
Performance |
| Timeline |
| Edgewise Therapeutics |
| Organon |
Edgewise Therapeutics and Organon Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Edgewise Therapeutics and Organon
The main advantage of trading using opposite Edgewise Therapeutics and Organon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Organon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will offset losses from the drop in Organon's long position.| Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
| Organon vs. Johnson Johnson | Organon vs. Bristol Myers Squibb | Organon vs. AbbVie Inc | Organon vs. Eli Lilly and |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |